Publications by authors named "Line Nederby"

Claim this Profile
N
Natural killer cell activity in prostate cancer patients treated with curative radiotherapy with or without androgen deprivation therapy: an observational study.
Stine V Eriksen, Christine V Madsen, Signe Timm, Ahmed H Zedan, Louise Raunkilde, Line Nederby

Acta Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural Killer Cell Activity and Response to Neoadjuvant Treatment in Breast Cancer Patients.
Sofie Høier Gamborg-Kvist, Else Maae, Signe Timm, Ina Mathilde Kjær, Troels Bechmann, Line Nederby

Int J Mol Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of Cellular Immune Response and Immunological Biomarkers in Laparoscopic Surgery for Colorectal Cancer and Benign Disorders.
Line Nederby, Natacha Dencker Trabjerg, Anja Bjørnskov Andersen, Jan Lindebjerg, Torben Frøstrup Hansen

Clin Colorectal Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy.
Sinne Søberg Brun, Torben Frøstrup Hansen, Sara Witting Christensen Wen, Christa Haugaard Nyhus, Lisbeth Bertelsen, Line Nederby

Sci Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Description of an activity-based enzyme biosensor for lung cancer detection.
Paul W Dempsey, Cristina-Mihaela Sandu, Ricardo Gonzalezirias, Spencer Hantula, Obdulia Covarrubias-Zambrano, Line Nederby

Commun Med (Lond)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.
Sara Witting Christensen Wen, Line Nederby, Rikke Fredslund Andersen, Torben Schjødt Hansen, Christa Haugaard Nyhus

Br J Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of circulating biomarkers for detection of lung cancer in a high-risk cohort.
Morten Borg, Line Nederby, Sara Witting Christensen Wen, Torben Frøstrup Hansen, Anders Jakobsen

Cancer Biomark· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Expression of the Costimulatory Checkpoint Factor DNAM-1 by CD4 T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens.
Katrine Fladeland Iversen, Line Nederby, Thomas Lund, Torben Plesner

Clin Hematol Int· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients.
Morten Borg, Sara Witting Christensen Wen, Torben Frøstrup Hansen, Anders Jakobsen, Rikke Fredslund Andersen, Line Nederby

J Int Med Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia exhibiting clonal instability during treatment: Implications for measurable residual disease assessments.
Anita T Simonsen, Manja Meggendorfer, Marcus H Hansen, Line Nederby, Sarah Koch

Exp Hematol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of the EarlyCDT® Lung test in detection of lung cancer and pulmonary metastases in a high-risk cohort.
Morten Borg, Sara W C Wen, Line Nederby, Torben Frøstrup Hansen, Anders Jakobsen

Lung Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validating Methylated HOXA9 in Bronchial Lavage as a Diagnostic Tool in Patients Suspected of Lung Cancer.
Sara W C Wen, Rikke F Andersen, Kristian Rasmussen, Caroline Brenner Thomsen, Torben Frøstrup Hansen, Line Nederby

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen Expression Varies Significantly between Molecular Subgroups of Acute Myeloid Leukemia Patients: Clinical Applicability Is Hampered by Establishment of Relevant Cutoffs.
Laura Laine Herborg, Line Nederby, Rasmus Froberg Brøndum, Maria Hansen, Peter Hokland

Acta Haematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood natural killer cells during treatment in recurrent ovarian cancer.
Jon Røikjær Henriksen, Line Nederby, Frede Donskov, Marianne Waldstrøm, Parvin Adimi

Acta Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling clonal heterogeneity at the stem cell level in myelodysplastic syndrome: In pursuit of cell subsets driving disease progression.
Anita Tranberg Simonsen, Marie Bill, Carina Agerbo Rosenberg, Marcus Høy Hansen, Peter Loof Møller, Line Nederby

Leuk Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy.
Jon Røikjær Henriksen, Line Nederby, Frede Donskov, Marianne Waldstrøm, Parvin Adimi

J Ovarian Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer.
Torben Frøstrup Hansen, Line Nederby, Ahmed H Zedan, Inge Mejlholm, Jon R Henriksen

Transl Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting CLEC12A as leukaemic stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy.
Marie Bill, Anni Aggerholm, Eigil Kjeldsen, Anne S Roug, Peter Hokland, Line Nederby

Br J Haematol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of NK cell activity using whole blood: Methodological aspects of a new test.
Line Nederby, Anders Jakobsen, Marianne Hokland, Torben Frostrup Hansen

J Immunol Methods· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CLEC12A receptor marks human basophils: Potential implications for minimal residual disease detection in acute myeloid leukemia.
Marie Toft-Petersen, Anne Stidsholt Roug, Trine Plesner, Lene Ebbesen, Gordon D Brown, Line Nederby

Cytometry B Clin Cytom· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the CLEC12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC12A-related cancer stem cell biology.
Marie Bill, Peter B van Kooten Niekerk, Petter S Woll, Laura Laine Herborg, Anne Stidsholt Roug, Line Nederby

J Cell Mol Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Exome sequencing identifies T-ALL with myeloid features as a -struck early precursor T-cell malignancy.
Marcus C Hansen, Line Nederby, Eigil Kjeldsen, Marianne A Petersen, Hans B Ommen

Leuk Res Rep· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.
Marie Toft-Petersen, Line Nederby, Eigil Kjeldsen, Gitte B Kerndrup, Gordon D Brown

Br J Haematol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel scripts for improved annotation and selection of variants from whole exome sequencing in cancer research.
Marcus Celik Hansen, Line Nederby, Anne Roug, Palle Villesen, Eigil Kjeldsen

MethodsX· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nature and nurture: a case of transcending haematological pre-malignancies in a pair of monozygotic twins adding possible clues on the pathogenesis of B-cell proliferations.
Marcus C Hansen, Charlotte G Nyvold, Anne S Roug, Eigil Kjeldsen, Palle Villesen, Line Nederby

Br J Haematol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis